NCT02997215

Brief Summary

This study was to evaluate the effect of intraoperative intravenous lidocaine on postoperative pain management after laparoscopic cholecystectomy. Half of patients will receive intravenous lidocaine during procedure, the rest half of patients will receive regular anesthesia care and placebo treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 19, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

December 19, 2016

Status Verified

December 1, 2016

Enrollment Period

11 months

First QC Date

December 6, 2016

Last Update Submit

December 16, 2016

Conditions

Keywords

intravenous lidocainepostoperative pain management

Outcome Measures

Primary Outcomes (4)

  • postoperative pain score

    visual analogue score (1-10)

    6 hours after surgery

  • postoperative pain score

    visual analogue score (1-10)

    24 hours after surgery

  • postoperative pain score

    visual analogue score (1-10)

    72 hours after surgery

  • total postoperative opioid consumption

    postoperative fentanyl consumption

    48 hours after surgery

Secondary Outcomes (1)

  • incidence of postoperative complication

    48 hours after surgery

Study Arms (2)

intravenous lidocaine

EXPERIMENTAL

intravenous lidocaine 1.5mg/kg during induction then infused at 2mg/kg/h until the end of procedure.

Drug: Lidocaine

saline placebo

PLACEBO COMPARATOR

same amount volume saline infusion

Drug: Saline Placebo

Interventions

lidocaine infusion during surgery

intravenous lidocaine

saline infusion at same rate as intervention group during surgery

saline placebo

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologist (ASA) status I-II adult patients undergoing elective laparoscopic cholecystectomy.

You may not qualify if:

  • Open surgery;
  • Patients allergic to lidocaine or other local anesthetics;
  • Drug abuser.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology; Beijing Tongren Hospital

Beijing, 100730, China

RECRUITING

MeSH Terms

Interventions

Lidocaine

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice-Chief Anesthesiologist

Study Record Dates

First Submitted

December 6, 2016

First Posted

December 19, 2016

Study Start

January 1, 2016

Primary Completion

December 1, 2016

Study Completion

May 1, 2017

Last Updated

December 19, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will share

De-identified individual participants data for primary and secondary outcome measures will be available within 6 months of study completion

Locations